Previous close | 1.7000 |
Open | 1.7400 |
Bid | 1.5500 |
Ask | 4.5000 |
Strike | 85.00 |
Expiry date | 2025-01-17 |
Day's range | 1.7000 - 1.7400 |
Contract range | N/A |
Volume | |
Open interest | 15 |
Revenue and Earnings Exceed Expectations, Highlighting Robust Growth and Operational Efficiency
While the top- and bottom-line numbers for Insulet (PODD) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
ACTON, Mass., May 09, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced financial results for the three months ended March 31, 2024.